Clinical Trials Logo
  1. Home
  2. Multiple Sclerosis
  3. NCT04447937
  4. Details
NCT04447937 Clinical Trial

Immunodeficiency in MS

Multiple Sclerosis Clinical Trial

Official title:
Analysis of Medical Therapy and History as Risks of Immunodeficiency in Multiple Sclerosis Patients

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04447937
Other study ID # NPI-110
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 29, 2020
Est. completion date July 30, 2021

Study information
Verified date June 2020
Source Advanced Neurosciences Institute
Contact Samuel F Hunter, MD, PhD
Phone 6157915470
Email sfhunter@neurosci.us
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to identify if there is a relationship between multiple sclerosis disease-modifying therapy exposure, immunodeficiencies, and infection risk in subjects living with MS.

Description:

The purpose of this study is to identify if there is a relationship between multiple sclerosis disease-modifying therapy exposure, immunodeficiencies, and infection risk in subjects living with MS. By understanding this relationship future studies can be designed to create a model of immunosenescence in multiple sclerosis, which could help healthcare providers to predict and assess health risks. Preventative strategies can then be tested to look for ways to prevent these immune-related risks.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 1500
Est. completion date July 30, 2021
Est. primary completion date January 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria

- One or more immunoglobulin level results and medical history available

- 18 years of age or older at the time of data collection

- Patients with first symptom MS or other isolated demyelinating syndromes, neuromyelitis optica, or rheumatic-associated CNS inflammation

Exclusion Criteria:

- No evidence of CNS autoimmune disease

- Less than 18 years of age at the time of data abstraction

- Undergoing plasma exchange at the time of any lab tests drawn

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• No Interventions
There are no interventions associated with the study.

Locations
Country Name City State
United States Advanced Neurosciences Institute Franklin Tennessee

Sponsors (2)
Lead Sponsor Collaborator
Advanced Neurosciences Institute Novel Pharmaceutics Institute

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Immunoglobulin Levels IgG, IgA, IgM 1 year
Secondary Infections Serious and non-serious 1 year
Secondary Immune-mediated conditions Serious and non-serious 1 year
Secondary Malignant and pre-malignant conditions Serious and non-serious 1 year
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4